# Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers:  Guidance for Industry and Review Staff - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/drug-and-device-manufacturer-communications-with-payors-formulary-committees-and-similar-entities-questions-and-answers-guidance-for-industry-and-review-staff/fef61098-3bf5-4dc1-8f77-41453aebdc3c

> FDA guidance document: Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers:  Guidance for Industry and Review Staff. Issue date: June 13, 2018. Get complete insights and analysis.

---

## Details

- Title: Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers:  Guidance for Industry and Review Staff
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-06-13
- Last Changed: 2024-11-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1307">FDA-2016-D-1307</a>

## Related Documents

- [Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers :  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/medical-product-communications-that-are-consistent-with-the-fda-required-labeling-questions-and-answers-guidance-for-industry/f5790b05-bd18-4236-a580-c2ae7ca2a444)
- [Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic](https://www.globalkeysolutions.net/guidances/guidance-document/postmarketing-adverse-event-reporting-for-medical-products-and-dietary-supplements-during-a-pandemic/98000d9a-b1f7-4dbc-8bf5-8079e3a4b3a7)
- [Tropical Disease Priority Review Vouchers](https://www.globalkeysolutions.net/guidances/guidance-document/tropical-disease-priority-review-vouchers/5a29b7d1-5c71-4f17-b7d0-4c04b9df5ed1)